EUVIMEDEUVIMED entdecken
Open Access

The prognostic value of selected indices combination in hepatocellular carcinoma patients treated with sorafenib

Radosław Osmański, Marcin Mardas, Maria Litwiniuk, Marta Stelmach-Mardas

Reports of Practical Oncology and Radiotherapy · 27.02.2026 · 31 (1) · 59-67

DOI: 10.5603/rpor.111180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports of Practical Oncology and Radiotherapy, online erschienen am 27.02.2026. Verfasst von Radosław Osmański und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Immuno-Oncology, Greater Poland Cancer Centre, Poznan, Poland. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ALBIMELDPNISIRIindicesliver

Autor:innen und Institutionen

  • Department of Oncology and Immuno-Oncology, Greater Poland Cancer Centre, Poznan, Poland.
  • Department of Gynecological Oncology, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Pathology and Cancer Prevention, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Medical Education and Communication, Poznan University of Medical Sciences, Poznan, Poland.

Zitieren

APA

Osmański, R., Mardas, M., Litwiniuk, M., & Stelmach-Mardas, M. (2026). The prognostic value of selected indices combination in hepatocellular carcinoma patients treated with sorafenib. Reports of Practical Oncology and Radiotherapy, 31(1), 59-67. https://doi.org/10.5603/rpor.111180

Vancouver

Osmański R, Mardas M, Litwiniuk M, Stelmach-Mardas M. The prognostic value of selected indices combination in hepatocellular carcinoma patients treated with sorafenib. Reports of Practical Oncology and Radiotherapy. 2026;31(1):59-67. doi:10.5603/rpor.111180

BibTeX
@article{Osmaski2026,
  author = {Osmański, Radosław and Mardas, Marcin and Litwiniuk, Maria and Stelmach-Mardas, Marta},
  title = {The prognostic value of selected indices combination in hepatocellular carcinoma patients treated with sorafenib},
  journal = {Reports of Practical Oncology and Radiotherapy},
  year = {2026},
  volume = {31},
  number = {1},
  pages = {59--67},
  doi = {10.5603/rpor.111180}
}
Kostenlos starten →